As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys.
On Friday, Hemispherx Biopharma's Exec. Vice Chairman/CEO/Pres., Thomas K. Equels, made a $118,498 buy of HEB, purchasing 29,404 shares at a cost of $4.03 each. Hemispherx Biopharma is trading up about 0.6% on the day Friday. Before this latest buy, Equels bought HEB on 5 other occasions during the past year, for a total investment of $69,556 at an average of $0.26 per share.
And on Monday, Chief Executive Officer H. Lawrence Webb purchased $49,997 worth of The New Home Company, purchasing 12,345 shares at a cost of $4.05 each. Before this latest buy, Webb purchased NWHM on 2 other occasions during the past year, for a total cost of $102,314 at an average of $3.87 per share. The New Home Company is trading down about 1.7% on the day Friday. Webb was up about 7.0% on the purchase at the high point of today's trading session, with NWHM trading as high as $4.33 in trading on Friday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.